Table 3.
Mortality | ||
---|---|---|
HR (95% CI) | P‐value | |
Age at symptom onset | 1.07 (0.99–1.15) | 0.091 |
Female | 8.03 (1.00–64.37) | 0.050 |
Cancer | 8.03 (1.00–64.37) | 0.050 |
SCLC | 18.18 (3.55–93.04) | <0.001 |
CNS | 2.71 (0.56–13.16) | 0.22 |
Cerebellar ataxia | 0.51 (0.11–2.47) | 0.40 |
Myelopathy | 3.83 (1.03–14.33) | 0.046 |
Autoimmune encephalopathy | 2.05 (0.51–8.29) | 0.32 |
Neuropathy/radiculopathy | 2.16 (0.54–8.71) | 0.28 |
Optic neuropathy | 0.48 (0.06–3.83) | 0.49 |
Bolded values indicate significant P‐value (<0.05).
Abbreviations: SCLC, small cell lung cancer; CNS, central nervous system; HR, hazard ratio; CI, confidence interval.